During exercise, skeletal muscle produces secret fibroblast growth factor-21 (FGF21), which can protect against low-grade systemic inflammation and reduce T2D risk via upregulating glycogenesis, downregulating gluconeogenesis, and lipogenesis in the liver [223]. The gene discussed is FGF21; the disease is type 2 diabetes mellitus.